Application 012703
- Type
- NDA
- Sponsor
- ASTRAZENECA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ELAVIL | AMITRIPTYLINE HYDROCHLORIDE | TABLET;ORAL | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
| 003 | ELAVIL | AMITRIPTYLINE HYDROCHLORIDE | TABLET;ORAL | 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
| 004 | ELAVIL | AMITRIPTYLINE HYDROCHLORIDE | TABLET;ORAL | 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
| 005 | ELAVIL | AMITRIPTYLINE HYDROCHLORIDE | TABLET;ORAL | 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
| 006 | ELAVIL | AMITRIPTYLINE HYDROCHLORIDE | TABLET;ORAL | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
| 007 | ELAVIL | AMITRIPTYLINE HYDROCHLORIDE | TABLET;ORAL | 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N012703-001 | ELAVIL | AMITRIPTYLINE HYDROCHLORIDE | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | ||
| N012703-003 | ELAVIL | AMITRIPTYLINE HYDROCHLORIDE | 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | ||
| N012703-004 | ELAVIL | AMITRIPTYLINE HYDROCHLORIDE | 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | ||
| N012703-005 | ELAVIL | AMITRIPTYLINE HYDROCHLORIDE | 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | ||
| N012703-006 | ELAVIL | AMITRIPTYLINE HYDROCHLORIDE | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | ||
| N012703-007 | ELAVIL | AMITRIPTYLINE HYDROCHLORIDE | 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N012703-001 | ELAVIL | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N012703-003 | ELAVIL | 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N012703-004 | ELAVIL | 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N012703-005 | ELAVIL | 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N012703-006 | ELAVIL | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N012703-007 | ELAVIL | 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | N012703-001 | ELAVIL | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N012703-003 | ELAVIL | 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N012703-004 | ELAVIL | 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N012703-005 | ELAVIL | 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N012703-006 | ELAVIL | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N012703-007 | ELAVIL | 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N012703-001 | ELAVIL | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N012703-003 | ELAVIL | 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N012703-004 | ELAVIL | 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N012703-005 | ELAVIL | 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N012703-006 | ELAVIL | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N012703-007 | ELAVIL | 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N012703-001 | ELAVIL | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N012703-003 | ELAVIL | 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N012703-004 | ELAVIL | 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N012703-005 | ELAVIL | 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N012703-006 | ELAVIL | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N012703-007 | ELAVIL | 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N012703-001 | ELAVIL | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N012703-003 | ELAVIL | 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N012703-004 | ELAVIL | 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N012703-005 | ELAVIL | 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N012703-006 | ELAVIL | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N012703-007 | ELAVIL | 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N012703-001 | ELAVIL | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N012703-003 | ELAVIL | 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N012703-004 | ELAVIL | 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N012703-005 | ELAVIL | 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N012703-006 | ELAVIL | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N012703-007 | ELAVIL | 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N012703-001 | ELAVIL | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N012703-003 | ELAVIL | 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N012703-004 | ELAVIL | 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N012703-005 | ELAVIL | 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | b8a1b40f171c… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Amitriptyline Hydrochloride | AMITRIPTYLINE HYDROCHLORIDE | A-S Medication Solutions | 9110367c-4104-4836-8af3-649f86b0b3ea | 2025-07-09 | Boxed warning, Warnings, Adverse reactions | AMITRIPTYLINE HYDROCHLORIDE |
| Amitriptyline Hydrochloride | AMITRIPTYLINE HYDROCHLORIDE | Major Pharmaceuticals | 29ec1221-04d8-4b21-822e-2779fcaae62c | 2025-06-27 | Boxed warning, Warnings, Adverse reactions | AMITRIPTYLINE HYDROCHLORIDE |
| Amitriptyline Hydrochloride | AMITRIPTYLINE HYDROCHLORIDE | A-S Medication Solutions | 85574987-8d31-4bd0-b829-bb154ef212f5 | 2025-06-24 | Boxed warning, Warnings, Adverse reactions | AMITRIPTYLINE HYDROCHLORIDE |
| Amitriptyline Hydrochloride | AMITRIPTYLINE HYDROCHLORIDE | Northstar Rx LLC. | 8ed28f42-e41a-45ca-a86f-849ebeb6ab80 | 2025-06-17 | Boxed warning, Warnings, Adverse reactions | AMITRIPTYLINE HYDROCHLORIDE |
| Amitriptyline Hydrochloride | AMITRIPTYLINE HYDROCHLORIDE | Unichem Pharmaceuticals (USA), Inc. | 9c6e0e05-b579-4fae-b768-e1a664c39bb8 | 2025-06-10 | Boxed warning, Warnings, Adverse reactions | AMITRIPTYLINE HYDROCHLORIDE |
| Amitriptyline Hydrochloride | AMITRIPTYLINE HYDROCHLORIDE | Sandoz Inc | 705a2bae-031d-4218-82fe-4346542c0baa | 2025-05-30 | Boxed warning, Warnings, Adverse reactions | AMITRIPTYLINE HYDROCHLORIDE |
| Amitriptyline Hydrochloride | AMITRIPTYLINE HYDROCHLORIDE | ST. MARY'S MEDICAL PARK PHARMACY | 35a6e911-507a-ef0d-e063-6294a90a07e1 | 2025-05-21 | Boxed warning, Warnings, Adverse reactions | AMITRIPTYLINE HYDROCHLORIDE |
| Amitriptyline Hydrochloride | AMITRIPTYLINE HYDROCHLORIDE | ST. MARY'S MEDICAL PARK PHARMACY | 35a7ce7d-4a29-e3f0-e063-6294a90ad66f | 2025-05-21 | Boxed warning, Warnings, Adverse reactions | AMITRIPTYLINE HYDROCHLORIDE |
| Amitriptyline Hydrochloride | AMITRIPTYLINE HYDROCHLORIDE | Bryant Ranch Prepack | 2bda8478-f5ab-440a-a8a3-61ebc5721369 | 2025-05-16 | Boxed warning, Warnings, Adverse reactions | AMITRIPTYLINE HYDROCHLORIDE |
| Amitriptyline Hydrochloride | AMITRIPTYLINE HYDROCHLORIDE | Bryant Ranch Prepack | 86bad1a5-48c3-4a8a-970f-8fdbda078b4e | 2025-05-15 | Boxed warning, Warnings, Adverse reactions | AMITRIPTYLINE HYDROCHLORIDE |
| Amitriptyline Hydrochloride | AMITRIPTYLINE HYDROCHLORIDE | Rising Pharma Holdings, Inc. | a219a68e-7ce5-4e9d-a0de-ec76960040f6 | 2025-04-03 | Boxed warning, Warnings, Adverse reactions | AMITRIPTYLINE HYDROCHLORIDE |
| Amitriptyline Hydrochloride | AMITRIPTYLINE HYDROCHLORIDE | Zydus Pharmaceuticals USA Inc. | 73669354-babc-4687-a4fe-ad0fc1f863ba | 2025-03-25 | Boxed warning, Warnings, Adverse reactions | AMITRIPTYLINE HYDROCHLORIDE |
| Amitriptyline Hydrochloride | AMITRIPTYLINE HYDROCHLORIDE | A-S Medication Solutions | bbbd535d-0bce-469e-917f-70a6ebd2f007 | 2025-02-24 | Boxed warning, Warnings, Adverse reactions | AMITRIPTYLINE HYDROCHLORIDE |
| Amitriptyline Hydrochloride | AMITRIPTYLINE HYDROCHLORIDE | A-S Medication Solutions | 69c7a0bd-93d0-40fe-a6d3-f41986b802b4 | 2025-02-24 | Boxed warning, Warnings, Adverse reactions | AMITRIPTYLINE HYDROCHLORIDE |
| Amitriptyline Hydrochloride | AMITRIPTYLINE HYDROCHLORIDE | AvPAK | f5c5f3b6-e92b-1120-e053-2995a90ae8fa | 2025-01-09 | Boxed warning, Warnings, Adverse reactions | AMITRIPTYLINE HYDROCHLORIDE |
| Amitriptyline Hydrochloride | AMITRIPTYLINE HYDROCHLORIDE | AvPAK | fd771b4b-c7ae-8e69-e053-6294a90a2120 | 2025-01-09 | Boxed warning, Warnings, Adverse reactions | AMITRIPTYLINE HYDROCHLORIDE |
| Amitriptyline Hydrochloride | AMITRIPTYLINE HYDROCHLORIDE | Advanced Rx of Tennessee, LLC | 082b620f-8085-d205-e063-6294a90ac6de | 2024-12-31 | Boxed warning, Warnings, Adverse reactions | AMITRIPTYLINE HYDROCHLORIDE |
| Amitriptyline Hydrochloride | AMITRIPTYLINE HYDROCHLORIDE | Advanced Rx Pharmacy of Tennessee, LLC | f98d25a7-6b47-38a9-e053-6394a90a541d | 2024-12-31 | Boxed warning, Warnings, Adverse reactions | AMITRIPTYLINE HYDROCHLORIDE |
| Amitriptyline Hydrochloride | AMITRIPTYLINE HYDROCHLORIDE | Advanced Rx Pharmacy of Tennessee, LLC | f78102eb-cbeb-801a-e053-6294a90ab880 | 2024-12-31 | Boxed warning, Warnings, Adverse reactions | AMITRIPTYLINE HYDROCHLORIDE |
| Amitriptyline Hydrochloride | AMITRIPTYLINE HYDROCHLORIDE | Advanced Rx of Tennessee, LLC | 19b0c015-c07f-63b7-e063-6394a90a6060 | 2024-11-18 | Boxed warning, Warnings, Adverse reactions | AMITRIPTYLINE HYDROCHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.